Semisynthesis of bersavine and berbamine derivatives that target the CaMKIIγ:cMyc axis for lymphoma therapy DOI

Berkley Lujan,

Mingfeng Zhang,

Yujie Cao

et al.

Organic & Biomolecular Chemistry, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Bersavine, a bisbenzylisoquinoline alkaloid (bisBIA), and its derivatives are promising leads for developing novel therapeutics to treat aggressive cancers such as lymphoma, by targeting the CaMKIIγ:cMyc axis.

Language: Английский

Semisynthesis of bersavine and berbamine derivatives that target the CaMKIIγ:cMyc axis for lymphoma therapy DOI

Berkley Lujan,

Mingfeng Zhang,

Yujie Cao

et al.

Organic & Biomolecular Chemistry, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Bersavine, a bisbenzylisoquinoline alkaloid (bisBIA), and its derivatives are promising leads for developing novel therapeutics to treat aggressive cancers such as lymphoma, by targeting the CaMKIIγ:cMyc axis.

Language: Английский

Citations

0